Sygnature Discovery North America
Research ServicesQuebec, Canada201-500 Employees
Sygnature Discovery North America is part of a global drug discovery contract research organization that provides integrated services from target identification through candidate nomination. Based in Saint-Laurent, Quebec, the company leverages a multi-disciplinary team to advance early-stage drug discovery programs for customers in the pharmaceutical, biotech, and non-profit sectors, focusing on oncology, inflammation and immunology, neuroscience, metabolic diseases, respiratory, infectious diseases and fibrotic diseases. The organization emphasizes confidentiality and collaboration across Europe and North America, working with clients to deliver rapid, high-quality scientific outcomes and to advance pre-clinical and clinical programs. Since its founding in 2004, Sygnature Discovery has accumulated extensive activity across numerous projects and patent applications, reflecting a sustained engagement with customers who rely on specialized expertise for complex discovery challenges. A recent development highlights collaboration and technology integration with partners to enhance its computational and medicinal chemistry toolkit, signaling ongoing expansion of its capabilities in support of client programs.
1-888-653-2347 
support@leadiq.com 
